Acambis restructures research operations

Acambis announced today that it is restructuring its research operations, following a strategic review to prioritise its extensive pipeline of development-stage projects.

Gordon Cameron, Acambis Acting chief executive officer commented: 'Acambis has never been in better shape. With our financial strengths and a clear vision of our key, high-value vaccine projects, we can deliver the maximum value for our shareholders.'